Circulating miR-193b-3p and miR-376a-3p Involved in Iranian Patients with Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  2019-04-10

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia

  2018cited by this paper
• Multiple sclerosis genetics.

  2018cited by this paper
• Identification of the miRNA–mRNA regulatory network in multiple sclerosis

  2017cited by this paper
• Circulating microRNAs as biomarkers in progressive multiple sclerosis

  2017cited by this paper
• Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity

  2017cited by this paper
• The role of microRNAs in the pathogenesis of autoimmune diseases.

  2016cited by this paper
• Is It worth Considering Circulating microRNAs in Multiple Sclerosis?

  2016cited by this paper
• Defining the clinical course of multiple sclerosis: The 2013 revisions

  2015cited by this paper
• Disease-modifying treatments for multiple sclerosis – a review of approved medications

  2015cited by this paper
• Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients

  2015cited by this paper
• Circulating microRNA biomarker studies: pitfalls and potential solutions.

  2015cited by this paper
• Integrative computational mRNA-miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17 differentiation regulators: An attempt to discover new potential miRNAs involved in Th17 differentiation.

  2015cited by this paper
• miRNA in multiple sclerosis: search for novel biomarkers

  2015cited by this paper
• Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression

  2014influential reference
• miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.

  2014influential reference
• Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis

  2014cited by this paper
• Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity—Preliminary Study

  2014cited by this paper
• Epidemiology of Multiple Sclerosis in Iran: A Systematic Review

  2013cited by this paper
• Selective secretion of microRNA in CNS system

  2013cited by this paper
• MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.

  2012cited by this paper
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

  2011cited by this paper
• Biological functions of microRNAs: a review

  2011cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Development of biomarkers in multiple sclerosis.

  2004cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• [Multiple sclerosis; review].

  1954cited by this paper

• miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis

  2023cites this paper
• MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose

  2022cites this paper
• Up-regulation of circulating miR-93-5p in patients with relapsing-remitting multiple sclerosis

  2019cites this paper